The patent, US #8,129,422 entitled ‘Methods and compositions for increasing the anaerobic working capacity in tissues’ adds to a suite of patents surrounding NAI’s CarnoSyn branded beta alanine and gives NAI the ability to move into animal dietary supplementation, said chairman Mark Le Doux.
“This new patent continues the recognition that patented beta-alanine based dietary supplements are uniquely beneficial to humans and animals alike."
NAI's new patent contains claims directed, in part, to methods of avoiding or delaying the onset of muscular fatigue through the use of beta-alanine compositions in several formulations. The methods cover humans as well as certain animals, said NAI.
Beta-alanine is the rate-limiting precursor of carnosine, which is claimed to decrease fatigue in athletes.